Mahban Pharmaceutical Group, one of Iran’s leading and influential pharmaceutical organizations, has joined the supporters of the 8th International Pharmex Middle East 2026 Exhibition.

With more than four decades of experience across the pharmaceutical supply chain, manufacturing and distribution, Active Pharmaceutical Ingredients (APIs), dietary supplements, cosmetics and personal care products, as well as the development of export markets, Mahban has established a prominent position within Iran’s pharmaceutical industry.

Drawing on specialized expertise, modern industrial infrastructure, and a highly skilled workforce, Mahban has consistently pursued technological development, localization of manufacturing, sustainable supply of essential medicines, and the enhancement of product quality in accordance with international GMP standards.

The participation of Mahban Pharmaceutical Group as a supporter of Pharmex Middle East 2026 reflects the group’s strategic commitment to advancing the pharmaceutical ecosystem, strengthening professional and industry interactions, and supporting the region’s largest gathering of stakeholders in pharmaceutical raw materials, technology, equipment, packaging, and pharmaceutical services.

The Pharmex Secretariat appreciates Mahban Pharmaceutical Group’s trust and support and hopes that, through the active participation of leading and influential companies, this event will further evolve into a platform for expanding industrial cooperation, facilitating knowledge exchange, showcasing innovations, and fostering impactful domestic and international partnerships.